Pharmaceutical Published Insights

Published Date : 30 Apr, 2026

The Global Tysabri Market is estimated to be valued at USD 1,572.7 Mn in 2026 and is expected to reach USD 1,120.3 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of -4.7% from 2026 to 2033. ... View more

Published Date : 30 Apr, 2026

The global Revlimid market is estimated to be valued at USD 10.80 Bn in 2026 and is expected to reach USD 4.77 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of -11.0% from 2026 to 2033.... View more

Published Date : 30 Apr, 2026

The Global Ibrance Market is estimated to be valued at USD 4.19 Bn in 2026 and is expected to reach USD 2.27 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of -8.4% from 2026 to 2033.... View more

Published Date : 30 Apr, 2026

The Global Cyclosporine Drug Market is estimated to be valued at USD 4.61 billion in 2026 and is expected to reach USD 6.76 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033. ... View more

Published Date : 30 Apr, 2026

The global pharmaceutical market is estimated to be valued at USD 1.96 Tn in 2026 and is expected to reach USD 3.43 Tn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033. The global pha... View more

Published Date : 30 Apr, 2026

The Global Venlafaxine Market is estimated to be valued at USD 3.75 Bn in 2026 and is expected to reach USD 5.65 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033. The global venlaf... View more

Published Date : 30 Apr, 2026

The Global Iron Supplement Market is estimated to be valued at USD 2.91 billion in 2026 and is expected to reach USD 3.88 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2026 to 2033.... View more

Published Date : 30 Apr, 2026

The global Ozempic market is estimated to be valued at USD 24.54 Bn in 2026 and is expected to reach USD 48.75 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 10.3% from 2026 to 2033. The global Oz... View more

Published Date : 30 Apr, 2026

The global calcitonin salmon market is estimated to be valued at USD 483.0 Mn in 2026 and is expected to reach USD 765.4 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033. the globa... View more

Published Date : 30 Apr, 2026

The global Wegovy market is estimated to be valued at USD 12.77 Bn in 2026 and is expected to reach USD 37.19 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 16.5% from 2026 to 2033. The global Wegovy m... View more

Published Date : 30 Apr, 2026

Herceptin Biologic and Biosimilar Market is estimated to be valued at USD 3.49 Bn in 2026 and is expected to reach USD 5.19 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033. Hercep... View more

Published Date : 30 Apr, 2026

The Global Stelara Market is estimated to be valued at USD 9,532.3 million in 2026 and is expected to reach USD 2,963.1 million by 2033, exhibiting a compound annual growth rate (CAGR) of -15.4% from 2026 to 2033. The global Stelar... View more

Published Date : 30 Apr, 2026

The global Epogen market is estimated to be valued at USD 105.5 Mn in 2026 and is expected to reach USD 32.1 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of -15.6% from 2026 to 2033. Th... View more

Published Date : 30 Apr, 2026

The Global Population Screening Market is estimated to be valued at USD 27.57 Bn in 2026 and is expected to reach USD 40.42 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033. The global pop... View more

Published Date : 30 Apr, 2026

The Global Actemra Market is estimated to be valued at USD 3,023.6 Mn in 2026 and is expected to reach USD 2,373.6 Mn by 2033, declining at a compound annual growth rate (CAGR) of -3.4% from 2026 to 2... View more

Published Date : 30 Apr, 2026

The global Eliquis market is estimated to be valued at USD 8.33 Bn in 2026 and is expected to reach USD 12.03 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033. ... View more

Published Date : 30 Apr, 2026

The Global Prediabetes Market is estimated to be valued at USD 9.54 Bn in 2026 and is expected to reach USD 16.67 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033. The global predi... View more

Published Date : 30 Apr, 2026

The global Zepbound market is estimated to be valued at USD 10.37 Bn in 2026 and is expected to reach USD 31.68 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 17.3% from 2026 to 2033. ... View more